Mito Health Is Moving to the United States: Here's What That Means for You
Mito Health is expanding to the United States, bringing AI-powered preventive health testing and personalized longevity insights to US customers. Here's what's changing and why.
As of January 2025, Mito Health is making the United States our primary home.
Our CEO Kenneth Lou relocated to San Francisco to lead the move. The US had already become our biggest market, and we wanted to be closer to where our customers are.
Why the US
The preventive health space in the US is growing fast. More people are moving beyond the standard annual physical and looking for real, data-driven insight into their health. They want to know their biological age, understand their cardiovascular risk, and take action before problems develop.
That’s the gap Mito Health fills. We give people the data, analysis, and expert support they need to stay ahead of their health, not just react to it.
What We Do
Mito Health is a preventive health platform. We test 100+ biomarkers covering cardiovascular health, metabolic function, hormones, inflammation, nutrient levels, and more. That’s roughly 10x what you’d get from a standard physical.
Every result is reviewed in the context of your lifestyle and family history. You get a personalized action plan and a 1:1 consultation with a health expert who walks you through what to focus on and why.
For those who want to go deeper, we partner with BodySpec for DEXA body composition scans and Prenuvo for preventive full-body MRIs.
Research shows that 90% of longevity is influenced by lifestyle. The challenge is knowing which areas of your health need attention. That’s where we come in.
What’s Changing
We’ve wound down in-person blood draw services in Singapore, where Mito Health originally launched. If you’re a Singapore-based member, your dashboard and account remain fully accessible. You can still upload results and track your health data.
In the US, we now have lab partners across all 50 states, making it easy to get tested wherever you are. You can read more about why we chose to focus on comprehensive biomarker testing on our blog.
What’s Next
We’re backed by Y Combinator and Forge Ventures with $4M raised. Our team includes Ryan Ware, our longevity-focused care team lead, and we recently welcomed Professor Brian Kennedy to our scientific advisory board.
We’ve also been proud to partner with events like the Bryan Johnson Don’t Die Summit as an official health diagnostics partner.
We’re focused on building the best preventive health experience in the US. If you want to know where your health actually stands, we’d love to help.
